REIT - Mortgage
Compare Stocks
2 / 10Stock Comparison
DX vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
DX vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Mortgage | REIT - Healthcare Facilities |
| Market Cap | $2.66B | $151.66B |
| Revenue (TTM) | $421M | $11.63B |
| Net Income (TTM) | $319M | $1.43B |
| Gross Margin | 99.9% | 39.1% |
| Operating Margin | 107.8% | 4.4% |
| Forward P/E | 9.5x | 79.7x |
| Total Debt | $13.91B | $21.38B |
| Cash & Equiv. | $930M | $5.03B |
DX vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Dynex Capital, Inc. (DX) | 100 | 103.8 | +3.8% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DX vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DX is the clearest fit if your priority is growth exposure.
- Rev growth 179.5%, EPS growth 65.8%, 3Y rev CAGR 33.4%
- 179.5% FFO/revenue growth vs WELL's 35.8%
- Lower P/E (9.5x vs 79.7x)
WELL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- 233.9% 10Y total return vs DX's 61.1%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 179.5% FFO/revenue growth vs WELL's 35.8% | |
| Value | Lower P/E (9.5x vs 79.7x) | |
| Quality / Margins | 75.8% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.13 vs DX's 0.54, lower leverage | |
| Dividends | 1.3% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +45.8% vs DX's +27.0% | |
| Efficiency (ROA) | 2.3% ROA vs DX's 1.8%, ROIC 0.5% vs 4.8% |
DX vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DX vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DX leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 27.6x DX's $421M. DX is the more profitable business, keeping 75.8% of every revenue dollar as net income compared to WELL's 12.3%. On growth, DX holds the edge at +3.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $421M | $11.6B |
| EBITDAEarnings before interest/tax | $572M | $2.8B |
| Net IncomeAfter-tax profit | $319M | $1.4B |
| Free Cash FlowCash after capex | $107M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +99.9% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +107.8% | +4.4% |
| Net MarginNet income ÷ Revenue | +75.8% | +12.3% |
| FCF MarginFCF ÷ Revenue | +25.3% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.2% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +93.3% | +22.5% |
Valuation Metrics
DX leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 5.4x trailing earnings, DX trades at a 97% valuation discount to WELL's 155.7x P/E. On an enterprise value basis, DX's 21.2x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.7B | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $15.6B | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | 5.40x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.55x | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 21.19x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 6.34x | 14.22x |
| Price / BookPrice ÷ Book value/share | 0.68x | 3.40x |
| Price / FCFMarket cap ÷ FCF | — | 53.25x |
Profitability & Efficiency
DX leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
DX delivers a 13.0% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to DX's 5.65x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs DX's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.0% | +3.5% |
| ROA (TTM)Return on assets | +1.8% | +2.3% |
| ROICReturn on invested capital | +4.8% | +0.5% |
| ROCEReturn on capital employed | +5.8% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 5.65x | 0.49x |
| Net DebtTotal debt minus cash | $13.0B | $16.3B |
| Cash & Equiv.Liquid assets | $930M | $5.0B |
| Total DebtShort + long-term debt | $13.9B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $10,792 for DX. Over the past 12 months, WELL leads with a +45.8% total return vs DX's +27.0%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs DX's 19.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +0.9% | +16.2% |
| 1-Year ReturnPast 12 months | +27.0% | +45.8% |
| 3-Year ReturnCumulative with dividends | +69.3% | +194.0% |
| 5-Year ReturnCumulative with dividends | +7.9% | +211.9% |
| 10-Year ReturnCumulative with dividends | +61.1% | +233.9% |
| CAGR (3Y)Annualised 3-year return | +19.2% | +43.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than DX's 0.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 98.6% from its 52-week high vs DX's 89.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.54x | 0.13x |
| 52-Week HighHighest price in past year | $14.93 | $219.59 |
| 52-Week LowLowest price in past year | $11.70 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +89.4% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 48.4 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 5.7M | 2.6M |
Analyst Outlook
WELL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates DX as "Hold" and WELL as "Buy". Consensus price targets imply 26.1% upside for DX (target: $17) vs 4.6% for WELL (target: $227). WELL is the only dividend payer here at 1.28% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $16.83 | $226.50 |
| # AnalystsCovering analysts | 14 | 34 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | — | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
DX leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WELL leads in 3 (Total Returns, Risk & Volatility).
DX vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is DX or WELL a better buy right now?
For growth investors, Dynex Capital, Inc.
(DX) is the stronger pick with 179. 5% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Dynex Capital, Inc. (DX) offers the better valuation at 5. 4x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DX or WELL?
On trailing P/E, Dynex Capital, Inc.
(DX) is the cheapest at 5. 4x versus Welltower Inc. at 155. 7x. On forward P/E, Dynex Capital, Inc. is actually cheaper at 9. 5x.
03Which is the better long-term investment — DX or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to +7. 9% for Dynex Capital, Inc. (DX). Over 10 years, the gap is even starker: WELL returned +233. 9% versus DX's +61. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DX or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Dynex Capital, Inc. 's 0. 54β — meaning DX is approximately 306% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 6% for Dynex Capital, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DX or WELL?
By revenue growth (latest reported year), Dynex Capital, Inc.
(DX) is pulling ahead at 179. 5% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: Dynex Capital, Inc. grew EPS 65. 8% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, DX leads at 33. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DX or WELL?
Dynex Capital, Inc.
(DX) is the more profitable company, earning 75. 9% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 75. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DX leads at 175. 6% versus 3. 3% for WELL. At the gross margin level — before operating expenses — DX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DX or WELL more undervalued right now?
On forward earnings alone, Dynex Capital, Inc.
(DX) trades at 9. 5x forward P/E versus 79. 7x for Welltower Inc. — 70. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DX: 26. 1% to $16. 83.
08Which pays a better dividend — DX or WELL?
In this comparison, WELL (1.
3% yield) pays a dividend. DX does not pay a meaningful dividend and should not be held primarily for income.
09Is DX or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, DX: +61. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DX and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
WELL pays a dividend while DX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.